We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract
Read MoreHide Full Article
Patterson Companies, Inc. (PDCO - Free Report) delivered third-quarter fiscal 2025 adjusted earnings per share (EPS) of 43 cents, which declined 27.1% year over year. The figure missed the Zacks Consensus Estimate by 30.7%.
GAAP EPS for the quarter was 35 cents, reflecting a decline of 32.7% from the year-ago figure.
PDCO’s Revenues in Detail
Revenues totaled $1.57 billion, reflecting a decline of 2.7% year over year. The figure missed the Zacks Consensus Estimate by 3.8%.
Internal sales (adjusted for the effects of currency translation, the net impact of an interest rate swap and contributions from recent acquisitions) decreased 2.4% year over year.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Pending Sale Transaction
In December, Patient Square Capital agreed to acquire Patterson Companies for approximately $4.1 billion in an all-cash transaction. The “Go-Shop” period, under which PDCO had the right to actively solicit and consider alternative acquisition proposals from third parties, expired on Jan. 21. Per the terms of the deal with Patient Square Capital, the acquisition is now expected to be completed in April, subject to the satisfaction of customary closing conditions.
In light of this pending acquisition, PDCO did not provide any guidance.
Patterson Companies, Inc. Price, Consensus and EPS Surprise
Its operations consist of two business segments — Dental and Animal Health.
In the quarter under review, the Dental segment reported revenues of $596.3 million, down 6.4% from the year-ago quarter’s level. The Zacks Consensus Estimate for fiscal third-quarter segmental revenues was pegged at $631.8 million.
The segment consists of three sub-segments — Consumable, Equipment and Value-added services and other.
Sales of Consumable totaled $327.6 million, down 6.6% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $343.2 million.
Equipment sales amounted to $196 million, down 7.3% from the year-ago figure. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $206 million.
Sales of value-added services totaled $72.8 million, down 2.7% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $82.5 million.
Revenues in the Animal Health segment totaled $972.4 million, up 0.5% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $972.9 million.
Internal sales increased 0.2% year over year in the reported quarter.
The segment consists of three sub-segments — Consumable, Equipment and Value-added services and other.
Sales of Consumable totaled $914.4 million in the reported quarter, up 0.3% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $913.2 million.
Internal sales of Consumable remained flat year over year in the reported quarter.
Sales of Equipment totaled $33.5 million, down 1.1% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $35 million.
Sales of Value-added services amounted to $24.5 million in the reported quarter, up 11.1% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $24.8 million.
Internal sales of Value-added services were up 10.8% year over year in the reported quarter.
PDCO’s Margin Analysis
In the quarter under review, gross profit decreased 8.6% year over year to $320.8 million. As a percentage of revenues, the gross margin of 20.4% contracted 130 basis points (bps) on a year-over-year basis. We had projected 21.7% of gross margin for the third quarter of fiscal 2025.
Operating expenses of $275.4 billion declined 2% year over year.
Operating profit totaled $45.4 million, reflecting a 35.1% plunge from the year-ago level. The operating margin contracted 140 bps to 2.9%.
Patterson Companies’ Financial Position
PDCO exited the third quarter of fiscal 2025 with cash and cash equivalents of $135 million compared with $157.9 million at the end of the fiscal second quarter. Total debt (including current debt obligations) at the end of third-quarter fiscal 2025 was $623.8 million compared with $450.4 million at the end of the fiscal second quarter.
Cumulative net cash used in operating activities at the end of the fiscal third quarter was $735.1 million compared with $719.8 million a year ago.
PDCO’s Zacks Rank and Stocks to Consider
PDCO currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the industry have been discussed below.
AVAH delivered a trailing four-quarter average earnings surprise of 135.00%. The company is expected to release fourth-quarter results in March. Its shares have lost 4% in the past six months against the industry’s 2.1% growth.
Alphatec (ATEC - Free Report) , carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 40% for 2025. Its earnings missed estimates in each of the trailing four quarters, delivering an average negative surprise of 12.60%.
ATEC’s shares have gained 87.7% against the industry’s 0.1% decline in the past six months.
Masimo (MASI - Free Report) , carrying a Zacks Rank #2 at present, has an estimated growth rate of 9.5% for 2025.
MASI’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 17.10%. Its shares have risen 47% against the industry’s 0.1% decline in the past six months. The company is scheduled to release fourth-quarter results today.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract
Patterson Companies, Inc. (PDCO - Free Report) delivered third-quarter fiscal 2025 adjusted earnings per share (EPS) of 43 cents, which declined 27.1% year over year. The figure missed the Zacks Consensus Estimate by 30.7%.
GAAP EPS for the quarter was 35 cents, reflecting a decline of 32.7% from the year-ago figure.
PDCO’s Revenues in Detail
Revenues totaled $1.57 billion, reflecting a decline of 2.7% year over year. The figure missed the Zacks Consensus Estimate by 3.8%.
Internal sales (adjusted for the effects of currency translation, the net impact of an interest rate swap and contributions from recent acquisitions) decreased 2.4% year over year.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Pending Sale Transaction
In December, Patient Square Capital agreed to acquire Patterson Companies for approximately $4.1 billion in an all-cash transaction. The “Go-Shop” period, under which PDCO had the right to actively solicit and consider alternative acquisition proposals from third parties, expired on Jan. 21. Per the terms of the deal with Patient Square Capital, the acquisition is now expected to be completed in April, subject to the satisfaction of customary closing conditions.
In light of this pending acquisition, PDCO did not provide any guidance.
Patterson Companies, Inc. Price, Consensus and EPS Surprise
Patterson Companies, Inc. price-consensus-eps-surprise-chart | Patterson Companies, Inc. Quote
Patterson Companies’Segmental Details
Its operations consist of two business segments — Dental and Animal Health.
In the quarter under review, the Dental segment reported revenues of $596.3 million, down 6.4% from the year-ago quarter’s level. The Zacks Consensus Estimate for fiscal third-quarter segmental revenues was pegged at $631.8 million.
The segment consists of three sub-segments — Consumable, Equipment and Value-added services and other.
Sales of Consumable totaled $327.6 million, down 6.6% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $343.2 million.
Equipment sales amounted to $196 million, down 7.3% from the year-ago figure. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $206 million.
Sales of value-added services totaled $72.8 million, down 2.7% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $82.5 million.
Revenues in the Animal Health segment totaled $972.4 million, up 0.5% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $972.9 million.
Internal sales increased 0.2% year over year in the reported quarter.
The segment consists of three sub-segments — Consumable, Equipment and Value-added services and other.
Sales of Consumable totaled $914.4 million in the reported quarter, up 0.3% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $913.2 million.
Internal sales of Consumable remained flat year over year in the reported quarter.
Sales of Equipment totaled $33.5 million, down 1.1% from the year-ago level. The Zacks Consensus Estimate for fiscal third-quarter revenues was pegged at $35 million.
Sales of Value-added services amounted to $24.5 million in the reported quarter, up 11.1% year over year on a reported basis. The Zacks Consensus Estimate for fiscal third-quarter revenues was pinned at $24.8 million.
Internal sales of Value-added services were up 10.8% year over year in the reported quarter.
PDCO’s Margin Analysis
In the quarter under review, gross profit decreased 8.6% year over year to $320.8 million. As a percentage of revenues, the gross margin of 20.4% contracted 130 basis points (bps) on a year-over-year basis. We had projected 21.7% of gross margin for the third quarter of fiscal 2025.
Operating expenses of $275.4 billion declined 2% year over year.
Operating profit totaled $45.4 million, reflecting a 35.1% plunge from the year-ago level. The operating margin contracted 140 bps to 2.9%.
Patterson Companies’ Financial Position
PDCO exited the third quarter of fiscal 2025 with cash and cash equivalents of $135 million compared with $157.9 million at the end of the fiscal second quarter. Total debt (including current debt obligations) at the end of third-quarter fiscal 2025 was $623.8 million compared with $450.4 million at the end of the fiscal second quarter.
Cumulative net cash used in operating activities at the end of the fiscal third quarter was $735.1 million compared with $719.8 million a year ago.
PDCO’s Zacks Rank and Stocks to Consider
PDCO currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the industry have been discussed below.
Avenna Healthcare (AVAH - Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated earnings growth rate of 666.7% for 2025. You can see the complete list of today’s Zacks #1 Rank stocks here.
AVAH delivered a trailing four-quarter average earnings surprise of 135.00%. The company is expected to release fourth-quarter results in March. Its shares have lost 4% in the past six months against the industry’s 2.1% growth.
Alphatec (ATEC - Free Report) , carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 40% for 2025. Its earnings missed estimates in each of the trailing four quarters, delivering an average negative surprise of 12.60%.
ATEC’s shares have gained 87.7% against the industry’s 0.1% decline in the past six months.
Masimo (MASI - Free Report) , carrying a Zacks Rank #2 at present, has an estimated growth rate of 9.5% for 2025.
MASI’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 17.10%. Its shares have risen 47% against the industry’s 0.1% decline in the past six months. The company is scheduled to release fourth-quarter results today.